These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25522898)

  • 61. Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) or familial Hibernian fever: presentation in a four-day-old infant.
    Savage T; Loftus BG; Tormey V; McDermott MF; Moylett E
    J Clin Rheumatol; 2008 Dec; 14(6):342-5. PubMed ID: 18690165
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes.
    Kuemmerle-Deschner JB; Hachulla E; Cartwright R; Hawkins PN; Tran TA; Bader-Meunier B; Hoyer J; Gattorno M; Gul A; Smith J; Leslie KS; Jiménez S; Morell-Dubois S; Davis N; Patel N; Widmer A; Preiss R; Lachmann HJ
    Ann Rheum Dis; 2011 Dec; 70(12):2095-102. PubMed ID: 21859692
    [TBL] [Abstract][Full Text] [Related]  

  • 63. First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS).
    Lucherini OM; Obici L; Ferracin M; Fulci V; McDermott MF; Merlini G; Muscari I; Magnotti F; Dickie LJ; Galeazzi M; Negrini M; Baldari CT; Cimaz R; Cantarini L
    PLoS One; 2013; 8(9):e73443. PubMed ID: 24066048
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Digenic MEFV/TNFRSF1A autoinflammatory syndrome with relapsing aseptic neutrophilic meningitis and chronic myelitis.
    Murarasu A; Dodé C; Sarrabay G; Klein I; Papo T; Sacré K
    Clin Exp Rheumatol; 2017; 35 Suppl 108(6):128-129. PubMed ID: 28134085
    [No Abstract]   [Full Text] [Related]  

  • 65. Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler's syndrome.
    de Koning HD; Schalkwijk J; van der Ven-Jongekrijg J; Stoffels M; van der Meer JW; Simon A
    Ann Rheum Dis; 2013 Oct; 72(10):1634-8. PubMed ID: 23087179
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identification of a new exon 2-skipped TNFR1 transcript: regulation by three functional polymorphisms of the TNFR-associated periodic syndrome (TRAPS) gene.
    Rittore C; Sanchez E; Soler S; Barat-Houari M; Albers M; Obici L; McDermott MF; Touitou I; Grandemange S
    Ann Rheum Dis; 2014 Jan; 73(1):290-7. PubMed ID: 23505244
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature.
    Gentileschi S; Rigante D; Vitale A; Sota J; Frediani B; Galeazzi M; Cantarini L
    Clin Rheumatol; 2017 Jul; 36(7):1687-1690. PubMed ID: 28536823
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Setting up TRAPS.
    Pettersson T; Kantonen J; Matikainen S; Repo H
    Ann Med; 2012 Mar; 44(2):109-18. PubMed ID: 21284532
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A new low-penetrance TNFRSF1A mutation causing atypical periodic fever.
    Rack A; Stojanov S; Belohradsky BH; Lohse P
    Pediatr Int; 2006 Apr; 48(2):169-71. PubMed ID: 16635178
    [No Abstract]   [Full Text] [Related]  

  • 70. "Periodic fever" without fever: two cases of non-febrile TRAPS with mutations in the TNFRSF1A gene presenting with episodes of inflammation or monosymptomatic amyloidosis.
    Kallinich T; Haffner D; Rudolph B; Schindler R; Canaan-Kühl S; Keitzer R; Burmester GR; Roesen-Wolff A; Roesler J
    Ann Rheum Dis; 2006 Jul; 65(7):958-60. PubMed ID: 16308343
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Identification of a novel mevalonate kinase gene mutation in combination with the common MVK V377I substitution and the low-penetrance TNFRSF1A R92Q mutation.
    Hoffmann F; Lohse P; Stojanov S; Shin YS; Renner ED; Kéry A; Zellerer S; Belohradsky BH
    Eur J Hum Genet; 2005 Apr; 13(4):510-2. PubMed ID: 15657603
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Missense mutation V20A in the tumor necrosis factor receptor superfamily 1A (TNFRSF1A) gene is associated with tumor necrosis factor receptor-associated periodic syndrome (TRAPS) presenting with periodic gastrointestinal symptoms.
    Yao Q; Yerian L; Shen B
    Inflamm Bowel Dis; 2011 Jun; 17(6):1445-6. PubMed ID: 21113948
    [No Abstract]   [Full Text] [Related]  

  • 73. Functional consequences of disease-associated mutations in TNFR1 elucidated by transcriptome analysis.
    Rebelo SL; Radford PM; Bainbridge SE; Todd I; Tighe PJ
    Adv Exp Med Biol; 2011; 691():461-70. PubMed ID: 21153350
    [No Abstract]   [Full Text] [Related]  

  • 74. A rare onset in tumour necrosis factor receptor-associated periodic syndrome: recurrent macrophage activation syndrome triggered by COVID-19 infection.
    Çağlayan Ş; Ulu K; Çakan M; Sözeri B
    Rheumatology (Oxford); 2022 Nov; 61(12):e366-e367. PubMed ID: 35731124
    [No Abstract]   [Full Text] [Related]  

  • 75. Interleukin-1 receptor antagonist deficiency with a novel mutation; late onset and successful treatment with canakinumab: a case report.
    Ulusoy E; Karaca NE; El-Shanti H; Kilicoglu E; Aksu G; Kutukculer N
    J Med Case Rep; 2015 Jun; 9():145. PubMed ID: 26100510
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Tumor necrosis factor-associated periodic syndrome in adults.
    Menon SG; Efthimiou P
    Rheumatol Int; 2018 Jan; 38(1):3-11. PubMed ID: 28942479
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in Japan: a review of the literature.
    Washio M; Nakano T; Kawaguchi Y; Takagi K; Kiyohara C; Tsukamoto H; Tokunaga S; Horiuchi T
    Mod Rheumatol; 2013 Mar; 23(2):210-7. PubMed ID: 22918594
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Brief Report: Involvement of TNFRSF11A molecular defects in autoinflammatory disorders.
    Jéru I; Cochet E; Duquesnoy P; Hentgen V; Copin B; Mitjavila-Garcia MT; Sheykholeslami S; Le Borgne G; Dastot-Le Moal F; Malan V; Karabina S; Mahevas M; Chantot-Bastaraud S; Lecron JC; Faivre L; Amselem S
    Arthritis Rheumatol; 2014 Sep; 66(9):2621-7. PubMed ID: 24891336
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Variable intrafamilial expressivity of the rare tumor necrosis factor-receptor associated periodic syndrome-associated mutation I170N that affects the TNFR1A cleavage site.
    Lehmann P; Salzberger B; Haerle P; Aksentijevich I; Kastner D; Schoelmerich J; Rosenfeld S; Mueller-Ladner U
    Mod Rheumatol; 2010 Jun; 20(3):311-5. PubMed ID: 20169391
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A Systematic Analysis of Treatment and Outcomes of NOD2-Associated Autoinflammatory Disease.
    Yao Q; Shen B
    Am J Med; 2017 Mar; 130(3):365.e13-365.e18. PubMed ID: 27984003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.